These, say the authors, likely suffice if cardiac biomarker results are normal/low and static. The review, with first author Lawrence Rudski, MD (Jewish General Hospital, McGill University, Montreal, Canada), was published this week in the Journal of the American College of Cardiology.Ĭardiac involvement is common in COVID-19, and the typical workup includes the standard combination of history, physical exam, lab tests, electrocardiography, and chest X-ray. “We felt that it might be helpful for clinicians out in the field to get an integrated expert view bringing in all the opinions, not just one subspecialty, and arriving at some consensus about what we think is most effective in this disease.”Īuthors on the document include “experts in imaging, but also experts in critical care cardiology, in heart failure, in interventional cardiology, and in general cardiology,” he added, “so it’s a really broad view of the field: of how not just the imagers but also the nonimagers view the relative utility of a given technique, given a set of clinical presentations.”
#HEART IMAGING HOW TO#
“In general, all of the societies have been putting out documents related to how to use their technique in the setting of COVID-19, whether that is related to requirements or whether that is related to clinical guidance,” senior author and council chair Marcelo Di Carli, MD (Brigham and Women’s Hospital, Boston, MA), told TCTMD.
Now, a multispecialty review commissioned by the Cardiovascular Imaging Leadership Council of the American College of Cardiology summarizes the available evidence and offers guidance for multimodal imaging in the setting of cardiac indications and confirmed or possible SARS-CoV-2 infection. Uncommon cardiac presentations, unstable patients, limited resources, and exposure risks to personnel-COVID-19 poses a range of complicating factors and special considerations for cardiac imaging.
0 kommentar(er)
